OCUL Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2023-05-01 | 2021 | Donald Notman Chief Financial Officer | 431,600 | 194,317 | 0 | 0 | 3,250 | 3,157,079 |
| 2023-05-01 | 2022 | Donald Notman Chief Financial Officer | 446,706 | 180,916 | 292,780 | 0 | 3,250 | 1,538,637 |
| 2023-05-01 | 2021 | Antony Mattessich President and Chief | 630,000 | 410,000 | 0 | 0 | 3,250 | 7,096,934 |
| 2023-05-01 | 2022 | Chief Medical Officer | 427,898 | 190,238 | 267,348 | 0 | 3,250 | 1,487,791 |
| 2023-05-01 | 2022 | Antony Mattessich President and Chief | 660,000 | 386,100 | 984,173 | 0 | 3,250 | 4,100,605 |
| 2022-05-02 | 2021 | Donald Notman Chief Financial Officer | 431,600 | 194,317 | 0 | 0 | 3,250 | 3,157,079 |
| 2022-05-02 | 2020 | Donald Notman Chief Financial Officer | 415,000 | 199,200 | 0 | 0 | 750 | 1,290,050 |
| 2022-05-02 | 2021 | Patricia Kitchen Former Chief Operating Officer | 168,438 | 0 | 0 | 0 | 293,000 | 3,388,494 |
| 2022-05-02 | 2020 | Patricia Kitchen Former Chief Operating Officer | 398,750 | 199,200 | 0 | 0 | 0 | 1,273,050 |
| 2022-05-02 | 2020 | Antony Mattessich President and Chief | 600,000 | 432,000 | 0 | 0 | 750 | 2,163,150 |
| 2022-05-02 | 2021 | Antony Mattessich President and Chief | 630,000 | 410,000 | 0 | 0 | 3,250 | 7,096,934 |
| 2022-05-02 | 2021 | Michael Goldstein, M.D. President, Ophthalmology and Chief Medical Officer | 488,250 | 244,247 | 0 | 0 | 3,250 | 4,061,947 |
| 2022-05-02 | 2020 | Michael Goldstein, M.D. President, Ophthalmology and Chief Medical Officer | 440,000 | 202,400 | 0 | 0 | 750 | 1,318,250 |
| 2021-04-29 | 2020 | Antony Mattessich President and Chief | 600,000 | 432,000 | 0 | 0 | 750 | 2,163,150 |
| 2021-04-29 | 2019 | Antony Mattessich President and Chief | 581,796 | 325,000 | 0 | 0 | 750 | 2,126,146 |
| 2021-04-29 | 2020 | Michael Goldstein, M.D. President, Ophthalmology and Chief Medical Officer | 440,000 | 220,400 | 0 | 0 | 750 | 1,336,250 |
| 2021-04-29 | 2019 | Michael Goldstein, M.D. President, Ophthalmology and Chief Medical Officer | 423,906 | 126,100 | 0 | 0 | 750 | 1,007,731 |
| 2021-04-29 | 2020 | Philip C. Strassburger, Esq. | 125,592 | 157,021 | 0 | 0 | 0 | 2,413,764 |
| 2020-04-29 | 2019 | Amarpreet Sawhney, Ph.D. ( 6 ) Former Chairman of the Board | 183,821 | 0 | 0 | 0 | 434 | 2,328,930 |
| 2020-04-29 | 2018 | Amarpreet Sawhney, Ph.D. ( 6 ) Former Chairman of the Board | 288,802 | 158,841 | 0 | 0 | 724 | 1,023,526 |
| 2020-04-29 | 2019 | Antony Mattessich ( 3 ) President and Chief | 581,796 | 325,000 | 0 | 0 | 750 | 2,126,146 |
| 2020-04-29 | 2018 | Daniel Bollag, Ph.D. ( 8 ) Former Chief Strategy Officer | 339,213 | 130,597 | 0 | 0 | 750 | 696,641 |
| 2020-04-29 | 2019 | Daniel Bollag, Ph.D. ( 8 ) Former Chief Strategy Officer | 352,984 | 0 | 0 | 0 | 29,866 | 1,040,883 |
| 2020-04-29 | 2018 | Antony Mattessich ( 3 ) President and Chief | 564,850 | 372,801 | 0 | 0 | 96,130 | 2,626,529 |
| 2020-04-29 | 2019 | Michael Goldstein, M.D. ( 4 ) Chief Medical Officer | 423,906 | 126,100 | 0 | 0 | 750 | 1,007,731 |
| 2020-04-29 | 2018 | Michael Goldstein, M.D. ( 4 ) Chief Medical Officer | 403,721 | 127,172 | 0 | 0 | 750 | 901,072 |
| 2020-04-29 | 2019 | Patricia Kitchen, Ph.D. ( 5 ) | 176,346 | 153,100 | 0 | 0 | 310,193 | 1,128,114 |
| 2019-04-25 | 2017 | Antony Mattessich ( 3 ) President and Chief | 237,628 | 596,500 | 0 | 0 | 154,963 | 6,181,799 |
| 2019-04-25 | 2018 | Antony Mattessich ( 3 ) President and Chief | 564,850 | 372,801 | 0 | 0 | 96,130 | 2,625,529 |
| 2019-04-25 | 2018 | Amarpreet Sawhney, Ph.D. ( 5 ) Chairman of the Board | 288,802 | 158,841 | 0 | 0 | 724 | 1,023,526 |
| 2019-04-25 | 2017 | Amarpreet Sawhney, Ph.D. ( 5 ) Chairman of the Board | 440,922 | 121,253 | 0 | 0 | 741 | 1,799,933 |
| 2019-04-25 | 2018 | Kevin Hanley ( 6 ) | 330,061 | 152,425 | 0 | 0 | 750 | 1,006,999 |
| 2018-04-23 | 2017 | James Fortune ( 8 ) Former Chief Operating Officer | 433,106 | 0 | 0 | 0 | 0 | 969,707 |
| 2018-04-23 | 2016 | James Fortune ( 8 ) Former Chief Operating Officer | 401,940 | 0 | 0 | 0 | 0 | 861,613 |
| 2018-04-23 | 2017 | Antony Mattessich ( 3 ) | 237,628 | 0 | 0 | 0 | 0 | 6,181,799 |
| 2018-04-23 | 2017 | Amarpreet Sawhney, Ph.D. ( 5 ) Executive Chairman of the Board | 440,922 | 0 | 0 | 0 | 0 | 1,799,933 |
| 2018-04-23 | 2016 | Amarpreet Sawhney, Ph.D. ( 5 ) Executive Chairman of the Board | 540,788 | 0 | 0 | 0 | 0 | 1,747,328 |
| 2018-04-23 | 2017 | Donald Notman ( 6 ) | 102,308 | 0 | 0 | 0 | 0 | 777,409 |
| 2018-04-23 | 2017 | Michael Goldstein ( 7 ) | 107,692 | 0 | 0 | 0 | 0 | 830,363 |
| 2017-04-20 | 2016 | Amarpreet Sawhney, Ph.D. President and Chief | 540,788 | 237,946 | 0 | 0 | 158 | 1,747,328 |
| 2017-04-20 | 2015 | James Fortune Chief Operating Officer | 388,348 | 110,679 | 0 | 0 | 2,801 | 2,022,357 |
| 2017-04-20 | 2016 | James Fortune Chief Operating Officer | 401,940 | 128,621 | 0 | 0 | 188 | 861,613 |
| 2017-04-20 | 2015 | W. Bradford Smith ( 6 ) Former Chief Financial Officer | 333,531 | 95,056 | 0 | 0 | 3,654 | 1,490,837 |
| 2017-04-20 | 2016 | W. Bradford Smith ( 6 ) Former Chief Financial Officer | 345,205 | 113,918 | 0 | 0 | 188 | 748,817 |
| 2017-04-20 | 2015 | Amarpreet Sawhney, Ph.D. President and Chief | 522,500 | 201,163 | 0 | 0 | 1,256 | 3,996,943 |
| 2015-04-24 | 2014 | Bradford Smith Chief Financial Officer | 248,750 | 76,781 | 0 | 0 | 1,215 | 1,059,368 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
